Design and Rationale of the REVEAL PET Study: A Study of (124)I-evuzamitide to Diagnose Cardiac Amyloidosis. Dorbala S, Maurer MS, Cuddy SAM, Auer BD, et al. J Nucl Cardiol 2026 Jun 15:102773. doi: 10.1016/j.nuclcard.2026.102773.

Read + Share

Amedeo Smart

Independent Medical Education

Dorbala S, Maurer MS, Cuddy SAM, Auer BD, et al. Design and Rationale of the REVEAL PET Study: A Study of (124)I-evuzamitide to Diagnose Cardiac Amyloidosis. J Nucl Cardiol 2026 Jun 15:102773. doi: 10.1016/j.nuclcard.2026.102773.
PMID: 42297126